Althea adds new aseptic fill/finish line amid cost concerns

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/RGtimeline)
(Image: iStock/RGtimeline)
Ajinomoto Althea, Inc. has added a new aseptic fill/finish line in response to client's concerns regarding active pharmaceutical ingredient (API) manufacturing costs.

The San Diego, CA-based contract development and manufacturing organization (CDMO) installed the Optima VFVM 7000 aseptic fill/finish line.

"All of our clients are concerned with the cost of manufacturing API. The ability to maximize yield from the filling line was a key driver for this project​," Stacy Sutton, head of engineering at Althea told Outsourcing-Pharma.com.

"This line has the capability to use two different pumping systems, rotary piston and peristaltic. The ability to use single use disposable filling assemblies in conjunction with peristaltic pumps is a key feature​," she added.

The line also has features to minimize drug product loss, including start and end of production modes, Sutton explained.

Additionally, the new line enables larger batch sizes and a wider filling volume range (0.2 mL up to 100 mL). The equipment also provides 100% in-process-control and nitrogen purging.

Related news

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Related suppliers